Global Anti-Cancer Drug Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 100

Report ID: 6373

Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.

The global Anti-Cancer Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Cancer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Cancer Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Merck
Bristol-Myers Squibb
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche Ltd.
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Avastin
Rituxan
Herceptin
Alimta

Segment by Application
Hospital
Clinic
Home Care

Table of Contents

Executive Summary
1 Anti-Cancer Drug Market Overview
1.1 Product Overview and Scope of Anti-Cancer Drug
1.2 Anti-Cancer Drug Segment by Type
1.2.1 Global Anti-Cancer Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Avastin
1.2.3 Rituxan
1.2.4 Herceptin
1.2.5 Alimta
1.3 Anti-Cancer Drug Segment by Application
1.3.1 Anti-Cancer Drug Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Anti-Cancer Drug Market by Region
1.4.1 Global Anti-Cancer Drug Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Anti-Cancer Drug Market Size
1.5.1 Global Anti-Cancer Drug Revenue (2014-2025)
1.5.2 Global Anti-Cancer Drug Production (2014-2025)

2 Global Anti-Cancer Drug Market Competition by Manufacturers
2.1 Global Anti-Cancer Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Anti-Cancer Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Anti-Cancer Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Anti-Cancer Drug Production Sites, Area Served, Product Types
2.5 Anti-Cancer Drug Market Competitive Situation and Trends
2.5.1 Anti-Cancer Drug Market Concentration Rate
2.5.2 Anti-Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Cancer Drug Production Market Share by Regions
3.1 Global Anti-Cancer Drug Production Market Share by Regions
3.2 Global Anti-Cancer Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Anti-Cancer Drug Production
3.4.1 North America Anti-Cancer Drug Production Growth Rate (2014-2019)
3.4.2 North America Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Anti-Cancer Drug Production
3.5.1 Europe Anti-Cancer Drug Production Growth Rate (2014-2019)
3.5.2 Europe Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Anti-Cancer Drug Production (2014-2019)
3.6.1 China Anti-Cancer Drug Production Growth Rate (2014-2019)
3.6.2 China Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Anti-Cancer Drug Production (2014-2019)
3.7.1 Japan Anti-Cancer Drug Production Growth Rate (2014-2019)
3.7.2 Japan Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Anti-Cancer Drug Consumption by Regions
4.1 Global Anti-Cancer Drug Consumption by Regions
4.2 North America Anti-Cancer Drug Consumption (2014-2019)
4.3 Europe Anti-Cancer Drug Consumption (2014-2019)
4.4 China Anti-Cancer Drug Consumption (2014-2019)
4.5 Japan Anti-Cancer Drug Consumption (2014-2019)

5 Global Anti-Cancer Drug Production, Revenue, Price Trend by Type
5.1 Global Anti-Cancer Drug Production Market Share by Type (2014-2019)
5.2 Global Anti-Cancer Drug Revenue Market Share by Type (2014-2019)
5.3 Global Anti-Cancer Drug Price by Type (2014-2019)
5.4 Global Anti-Cancer Drug Production Growth by Type (2014-2019)

6 Global Anti-Cancer Drug Market Analysis by Applications
6.1 Global Anti-Cancer Drug Consumption Market Share by Application (2014-2019)
6.2 Global Anti-Cancer Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Anti-Cancer Drug Business
7.1 Merck
7.1.1 Merck Anti-Cancer Drug Production Sites and Area Served
7.1.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.1.3 Merck Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Anti-Cancer Drug Production Sites and Area Served
7.2.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.2.3 Bristol-Myers Squibb Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Bayer
7.3.1 Bayer Anti-Cancer Drug Production Sites and Area Served
7.3.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.3.3 Bayer Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Anti-Cancer Drug Production Sites and Area Served
7.4.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.4.3 GlaxoSmithKline Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Novartis
7.5.1 Novartis Anti-Cancer Drug Production Sites and Area Served
7.5.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.5.3 Novartis Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Sanofi
7.6.1 Sanofi Anti-Cancer Drug Production Sites and Area Served
7.6.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.6.3 Sanofi Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Pfizer
7.7.1 Pfizer Anti-Cancer Drug Production Sites and Area Served
7.7.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.7.3 Pfizer Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Amgen
7.8.1 Amgen Anti-Cancer Drug Production Sites and Area Served
7.8.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.8.3 Amgen Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Celgene Corporation
7.9.1 Celgene Corporation Anti-Cancer Drug Production Sites and Area Served
7.9.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.9.3 Celgene Corporation Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Ariad Pharmaceuticals
7.10.1 Ariad Pharmaceuticals Anti-Cancer Drug Production Sites and Area Served
7.10.2 Anti-Cancer Drug Product Introduction, Application and Specification
7.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Eli Lilly
7.12 Hoffmann-La Roche Ltd.
7.13 AstraZeneca
7.14 Boehringer Ingelheim GmbH
7.15 Teva Pharmaceuticals

8 Anti-Cancer Drug Manufacturing Cost Analysis
8.1 Anti-Cancer Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Anti-Cancer Drug
8.4 Anti-Cancer Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Anti-Cancer Drug Distributors List
9.3 Anti-Cancer Drug Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Anti-Cancer Drug Market Forecast
11.1 Global Anti-Cancer Drug Production, Revenue Forecast
11.1.1 Global Anti-Cancer Drug Production Growth Rate Forecast (2019-2025)
11.1.2 Global Anti-Cancer Drug Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Anti-Cancer Drug Price and Trend Forecast (2019-2025)
11.2 Global Anti-Cancer Drug Production Forecast by Regions (2019-2025)
11.2.1 North America Anti-Cancer Drug Production, Revenue Forecast (2019-2025)
11.2.2 Europe Anti-Cancer Drug Production, Revenue Forecast (2019-2025)
11.2.3 China Anti-Cancer Drug Production, Revenue Forecast (2019-2025)
11.2.4 Japan Anti-Cancer Drug Production, Revenue Forecast (2019-2025)
11.3 Global Anti-Cancer Drug Consumption Forecast by Regions (2019-2025)
11.3.1 North America Anti-Cancer Drug Consumption Forecast (2019-2025)
11.3.2 Europe Anti-Cancer Drug Consumption Forecast (2019-2025)
11.3.3 China Anti-Cancer Drug Consumption Forecast (2019-2025)
11.3.4 Japan Anti-Cancer Drug Consumption Forecast (2019-2025)
11.4 Global Anti-Cancer Drug Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Anti-Cancer Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer